← Eichor
Condition: Inclusion Body Myositis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Inclusion Body Myositis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis
EARLY_Phase 1 · 2 location(s) · Austin Neuromuscular Center · NCT06479863Ruxolitinib Treatment in Inclusion Body Myositis
Phase 2 · 21 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06536166Adult and Juvenile Myositis
Phase N/A · 4 location(s) · National Institute of Environmental Health Sciences (NIEHS) · NCT00017914MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
Phase N/A · 1 location(s) · Myositis International Health & Research Collaborative Allia · NCT07374107Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
NA · 1 location(s) · University of Missouri-Columbia · NCT07478172
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.